122 related articles for article (PubMed ID: 31776303)
1. Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
Ito Y; Miyauchi A; Yamamoto M; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2020 Mar; 67(3):275-282. PubMed ID: 31776303
[TBL] [Abstract][Full Text] [Related]
2. Appropriateness of the revised Japanese guidelines' risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients.
Ito Y; Miyauchi A; Oda H; Masuoka H; Higashiyama T; Kihara M; Miya A
Endocr J; 2019 Feb; 66(2):127-134. PubMed ID: 30626761
[TBL] [Abstract][Full Text] [Related]
3. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of poorly differentiated carcinoma in Japanese Society of Thyroid Surgery in a series of papillary thyroid carcinoma patients: comparison with risk classification system in Kuma Hospital.
Ito Y; Hirokawa M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(9):817-21. PubMed ID: 22673534
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma.
Takami H; Ito Y; Okamoto T; Onoda N; Noguchi H; Yoshida A
World J Surg; 2014 Aug; 38(8):2002-10. PubMed ID: 24671301
[TBL] [Abstract][Full Text] [Related]
6. Migration of Risk Classification Between the JAES Versus ATA guidelines for Papillary Thyroid Carcinoma.
Yamazaki H; Masudo K; Rino Y
World J Surg; 2023 Jul; 47(7):1729-1737. PubMed ID: 36920523
[TBL] [Abstract][Full Text] [Related]
7. Improvement of lymph node recurrence rate, but not distant recurrence and carcinoma death rates, in patients with papillary thyroid carcinoma after disease-free survival for 5 years.
Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(10):895-901. PubMed ID: 22785260
[TBL] [Abstract][Full Text] [Related]
8. Prognosis and prognostic factors of patients with papillary carcinoma showing distant metastasis at surgery (M1 patients) in Japan.
Ito Y; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2010; 57(6):523-31. PubMed ID: 20379035
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
10. Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification.
Pérez-Soto RH; Velázquez-Fernández D; Arellano-Gutiérrez G; Chapa-Ibargüengoitia M; Trolle-Silva AM; Iñiguez-Ariza N; Pérez-Enríquez B; Sierra-Salazar M; Pantoja Millán JP; Herrera MF
Thyroid; 2020 Jun; 30(6):857-862. PubMed ID: 32031061
[No Abstract] [Full Text] [Related]
11. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
[TBL] [Abstract][Full Text] [Related]
12. Subclassification of Tumor Extension and Nodal Metastasis in Papillary Thyroid Cancer to Improve Prognostic Accuracy of the Eighth Edition of the Tumor-Node-Metastasis Classification.
Ito Y; Miyauchi A; Kihara M; Masuoka H; Higashiyama T; Miya A
World J Surg; 2020 Feb; 44(2):336-345. PubMed ID: 31428837
[TBL] [Abstract][Full Text] [Related]
13. The Prognosis of Papillary Thyroid Cancer with Initial Distant Metastasis is Strongly Associated with Extensive Extrathyroidal Extension: A Retrospective Cohort Study.
Lee YK; Kim D; Shin DY; Lee CR; Lee EJ; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
Ann Surg Oncol; 2019 Jul; 26(7):2200-2209. PubMed ID: 30895495
[TBL] [Abstract][Full Text] [Related]
14. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
15. Older Age Significantly Affects Mortality of Patients with Papillary Thyroid Carcinoma Only When They Have High-Risk Features.
Ito Y; Miyauchi A; Higashiyama T; Masuoka H; Kihara M; Miya A
World J Surg; 2020 Jun; 44(6):1885-1891. PubMed ID: 32095856
[TBL] [Abstract][Full Text] [Related]
16. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
Rosário PW; Calsolari MR
Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
[TBL] [Abstract][Full Text] [Related]
17. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma?
Harries V; Wang LY; McGill M; Xu B; Tuttle RM; Wong RJ; Shaha AR; Shah JP; Ghossein R; Patel SG; Ganly I
Surgery; 2020 Jan; 167(1):10-17. PubMed ID: 31515125
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years.
Ito Y; Kihara M; Takamura Y; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
Endocr J; 2012; 59(7):539-45. PubMed ID: 22472193
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Extranodal Tumor Extension in Papillary Thyroid Carcinoma: Proposal for Upstaging of Cases with Extranodal Tumor Extension.
Ito Y; Miyauchi A; Masuoka H; Higashiyama T; Kihara M; Miya A
World J Surg; 2020 Feb; 44(2):638-643. PubMed ID: 31605175
[TBL] [Abstract][Full Text] [Related]
20. Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma.
Ito Y; Ichihara K; Masuoka H; Fukushima M; Inoue H; Kihara M; Tomoda C; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2010 Nov; 34(11):2570-80. PubMed ID: 20625728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
